Skip to main content Back to Top
Advertisement

7/15/2022

14.6% Sodium Chloride Concentrated Solution for Injection

Products Affected - Description

    • 14.6% Sodium Chloride solution for injection, Fresenius Kabi, 20 mL vial, 25 count, NDC 63323-0090-20
    • 14.6% Sodium Chloride solution for injection, Fresenius Kabi, 40 mL vial, 25 count, NDC 63323-0090-40
    • 14.6% Sodium Chloride solution for injection, Pfizer, 40 mL vial, 25 count, NDC 00409-6660-75

Reason for the Shortage

    • Fresenius Kabi did not provide a reason for the shortage.
    • Pfizer has 14.6% sodium chloride injection on shortage due to increased demand.

Available Products

    • There are no presentations available

Estimated Resupply Dates

    • Fresenius Kabi has 14.6% sodium chloride 20 mL vials on back order and the company cannot estimate a release date. The 40 mL vials are on back order and the company estimates a release date of mid-August 2022.
    • Pfizer has 14.6% sodium chloride 40 mL vials on back order and the company estimates a release date of March 2023.

Updated

Updated July 15, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 17, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.